… In this review, we briefly introduce current treatments and pathophysiology of PD. In
addition, we address the novel innovative therapeutic targets for PD therapy, including α-synuclein, …

… boost the cellular antioxidant defense system and related molecules, … cell survival systems
[26–31], suggesting that these phytochemicals have therapeutic potential for the treatment of …

… disease-modifying treatments is of great scientific interest for many groups. Thus, this review
summarizes recent progress and perspectives regarding novel therapies for APS (Figure 1). …

… This article aims to address the general aspects of PD and to … latest therapeutic advancements
and emerging treatments for … perspective of mitochondrial biology in Parkinson’s disease. …

… progressive disorder especially the increasing severity of treatment-resistant motor and
non-… the clinical features and diagnostic criteria of PD, summarized the molecular mechanisms …

… of the disease. Studies in animal models and human post-mortem tissue have identified distinct
cellular and molecular … between different glial cell types and various molecular pathways. …

… in the pathogenesis of Parkinson’s disease. As … of Parkinson’s disease [16]. A number of
potential contributors to OS have been implicated in the disease process of Parkinson’s disease…

… fetal cell-derived therapies… Parkinson disease features that dopamine cell replacement
based on generating neurons from human pluripotent stem cells could effectively treat in the future…

… arsenal for the further development of efficient, nontoxic, and non-invasive therapeutic
protocols for disease-modifying therapy that tackles disease onset and progression in the future. …

… use in the treatment of PD. We furthermore review current evidence of the L-dopa-… side
effects and perspectives of L-dopa treatment in PD compared to other established treatments …